Safety Evaluation and Acceptable Daily Intake

Before a food additive may be authorised, its safety is evaluated through toxicological testing that identifies the highest dose producing no adverse effect, the no-observed-adverse-effect level (NOAEL). To translate this animal-derived value into a human guidance figure, the NOAEL is divided by an uncertainty (safety) factor, conventionally 100, to yield the acceptable daily intake (ADI), the amount expressed per kilogram of body weight that can be consumed daily over a lifetime without appreciable risk.

Definition

The acceptable daily intake is an estimate of the amount of a food additive, expressed on a body-weight basis, that can be ingested daily over a lifetime without appreciable health risk, derived by dividing the no-observed-adverse-effect level by an uncertainty factor that allows for inter-species and inter-individual variation.

Scope

The entry explains the toxicological logic behind additive safety evaluation, the derivation of the ADI from the NOAEL using uncertainty factors, and the comparison of estimated dietary exposure with the ADI. It is a reference account of the assessment framework, not clinical or dietary advice.

Core questions

• How is the no-observed-adverse-effect level determined from toxicological testing?
• How is the acceptable daily intake derived from the NOAEL?
• What does the conventional 100-fold uncertainty factor represent?
• How is estimated dietary exposure compared with the ADI?

Key concepts

• No-observed-adverse-effect level (NOAEL)
• Acceptable daily intake (ADI)
• Uncertainty (safety) factor
• Inter-species and inter-individual variation
• Toxicokinetics and toxicodynamics
• Dietary exposure assessment
• Risk characterisation

Mechanisms

Safety evaluation proceeds from a battery of toxicological studies that establish the NOAEL for the most sensitive adverse effect in the most sensitive species. The NOAEL is divided by an uncertainty factor, conventionally 100, understood as the product of a tenfold allowance for differences between test animals and humans and a tenfold allowance for variation among humans. Renwick proposed that each tenfold factor can be subdivided into toxicokinetic and toxicodynamic components, so that chemical-specific data may replace the default subfactors where available (Renwick, 1993; Walton et al., 1999). The resulting ADI is then compared with estimated dietary exposure in a risk-characterisation step.

Clinical relevance

The ADI framework explains how regulators decide that an additive's expected intake is unlikely to pose appreciable risk, which is useful background for interpreting safety statements about additives. It describes how population-level guidance figures are set and is not a personalised exposure limit or treatment recommendation.

Evidence & guidelines

International risk-assessment methodology is set out by expert bodies; the Joint FAO/WHO Expert Committee on Food Additives describes the principles for deriving health-based guidance values such as the ADI (Joint FAO/WHO Expert Committee on Food Additives, 2009). The structure and refinement of the uncertainty factor, including the option to replace default subfactors with chemical-specific data, are analysed in the toxicological literature (Renwick, 1993; Walton et al., 1999).

History

The acceptable-daily-intake concept emerged in mid-twentieth-century food toxicology as a way to express a tolerable lifetime exposure derived from animal data. The conventional 100-fold factor became standard, and later work, notably by Renwick, refined it by separating species and individual differences into toxicokinetic and toxicodynamic subfactors, allowing data-derived adjustment.

Debates

Should the default 100-fold uncertainty factor be replaced by data-derived factors?

The conventional factor is a pragmatic default, but proposals to subdivide it into toxicokinetic and toxicodynamic components and substitute chemical-specific data aim to make the ADI more accurate where adequate data exist, while preserving protection where they do not.

Key figures

• Andrew G. Renwick

Seminal works

• renwick-1993
• walton-1999
• jecfa-principles-2009

Frequently asked questions

What does the acceptable daily intake represent?

It is an estimate of how much of an additive, per kilogram of body weight, a person could consume every day across a lifetime without appreciable health risk, derived from toxicological testing and an uncertainty factor.

Why is the no-observed-adverse-effect level divided by 100?

The conventional 100-fold factor is treated as a tenfold allowance for differences between test animals and humans multiplied by a tenfold allowance for variation among humans, providing a margin between the safe animal dose and the human guidance value.